Skip to Main

Search

Results 4,351 to 4,360 of 10,000 for ""

Bioengineering the body to make its own medicine : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/march-bioengineering-the-body.html

Delivering genetic material tagged with a cellular “ZIP code” prompted cells to secrete proteins or drugs into the bloodstream that successfully treated psoriasis and cancer in mouse models, UT Southwestern Medical Center scientists report in a new study.

SLP ASHA Awardees: Otolaryngology News & Events - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/departments/otolaryngology/news-events/slp-asha-awardees.html

SLP ASHA Awardees Cory Atkinson, M.A., CCC-SLP April 16, 2026 Laura Toles, Ph.D., CCC-SLP, and Adrianna Shembel, Ph.D., CCC-SLP, were presented with Early Career Contributions in Research awards. Congratulations to three of our UT Southwestern Voice Center speech-language pathologists! The American S…

Nearly 100% of UT Southwestern medical students match to residency programs nationally, across Texas : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/march-match-day.html

Nearly 100% of UT Southwestern Medical School students matched to residency programs – well above the national average of 94%.

Who should complete CITI COI Training?

https://www.utsouthwestern.edu/research/research-support/conflict-of-interest/citi-coi.html

Who needs to take CITI COI training at UT Southwestern Medical Center

Advancing Understanding and Treatment of Sensorimotor Voice Disorders: Otolaryngology News & Events - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/departments/otolaryngology/news-events/advancing-understanding-and-treatment.html

Advancing Understanding and Treatment of Sensorimotor Voice Disorders: Three NIH-Funded Projects at the UT Larynx Lab Adrianna C. Shembel, Ph.D., CCC-SLP April 16, 2026 The UTSW Larynx Lab is leading several groundbreaking NIH-funded research initiatives aimed at improving diagnosis and treatment for…

UT Southwestern rheumatologist recommends patients receive pneumococcal vaccine : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-pneumococcal-vaccine.html

Patients with rheumatoid arthritis, lupus, and other rheumatic conditions are more at risk for complications and death from pneumonia, meningitis, and other bacterial infections, yet most have not been vaccinated against infection.

Robotic bronchoscopy may offer solution to lung biopsy risks: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-robotic-bronchoscopy.html

Lung nodule biopsies performed with new robotic bronchoscopy technology may be safer and more effective than those done by traditional methods, a study by researchers at UT Southwestern suggests.

Study links chronic pain to quality of family relationships: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/june-chronic-pain.html

– Strong family relationships have long been associated with a better sense of well-being and connection. Now a research team led by UT Southwestern Medical Center has linked the quality of those relationships with how successfully people – particularly aging African Americans – manage pain.

UTSW surgeon implants artificial sphincter to improve quality of life after prostate cancer surgery: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-firefighter-relief.html

A first responder for almost four decades, Roger McCurley had made hundreds of hospital runs while providing emergency service to people in the midst of the worst days of their lives.

COVID-19 vaccine’s effectiveness diminishes with age, UTSW research shows: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/november-covid-19-vaccines-effectiveness.html

The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.